Table 3: Data on baseline coagulation tests, pro-coagulant and anti-coagulant proteins in the patients and controls.

VariablesPatients ( )Controls ( )

PT (sc)11.1 (1.22)11.1 (1.00)0.643*
aPTT (sc)34.9 ± 4.9835.9 ± 5.120.321
INR (ratio)1.0 (0.11)1.0 (0.09)0.662*
Fibrinogen (mg/dL)244.1 ± 81.35292.5 ± 81.020.039
TT (sc)19.4 (3.20)14.1 (2.60)0.029*
FII (%)102.7 (30.25)114.5 (23.60)0.123*
FV (%)114.6 ± 31.60123.8 ± 22.070.080
FVII (%)84.0 ± 20.8384.1 ± 17.990.983
FVIII (%)82.2 (43.50)91.5 (38.00)0.028*
FIX (%)95.6 ± 29.2894.5 ± 31.860.860
FX (%)100.7 ± 25.87109.9 ± 25.040.063
FXII (%)121.2 ± 30.13122.2 ± 34.840.875
FXII (%)131.5 ± 27.70120.3 ± 35.870.072
AP (%)119.6 ± 18.42124.1 ± 14.020.155
vWF (%)105.1 (66.35)93.4 (61.80)0.025*
AT (%)98.5 ± 28.22115.3 ± 26.380.002
PC (%)81.5 (52.75)92.0 (58.00)0.022*
PS (%)73.4 ± 24.6383.2 ± 20.100.026
fPS (%)84.1 ± 18.10100.9 ± 20.31<0.001
PL (%)91.0 (44.00)99.0 (37.00)0.184*
APCR (R)3.0 (0.40)2.9 (0.40)0.127*
LA (R)1.0 (0.18)1.1 (0.17)0.189*

AP: antiplasmin; AT: antithrombin; F: factor; fPS: free protein S; PC: protein C; PL: plasminogen; PS: protein S; PT: prothrombin time; aPTT: activated partial thromboplastin time; TT: thrombin time; vWF: von Willebrand’s factor. *Mann Whitney U, Student’s t-test.